Skip to content
COMPANY
PRODUCTS
R & D
Product Candidates Overview
Pipeline
Orphan Drug Designations
PARTNERING
INVESTOR RELATIONS
Press Releases
Events & Presentations
Stock Information
SEC Filings
XBRL Filings
Stockholder Meeting
Corporate Governance
Email Alerts
Investor Contact
BLOG
CONTACT
Press Releases
Jul 01, 2002
Hemispherx Announces Annual Shareholders Meeting To Be Held August 14th, 2002
Jun 18, 2002
Abstracts cover latest developments in the Company's HIV/AIDS Clinical Trials for Salvage Therapy and Strategic Treatment Intervention (STI)
Jun 10, 2002
Hemispherx Biopharma Receives New Patent In Europe For Oral Dosed Broad-Spectrum Immune Activators
Jun 05, 2002
Hemispherx Biopharma Europe S.A. Completes Agreement With Laboratorios Del Dr. Esteve S.A.
May 16, 2002
AUDIO WEB REPLAY OF HEMISPHERX'S MAY 16, 2002 CONFERENCE CALL AVAILABLE ON COMPANY'S WEBSITE
May 15, 2002
HEMISPHERX TO HOST CONFERENCE CALL ON FIRST QUARTER RESULTS AND NEW HIV/AIDS ACTIVITY
May 15, 2002
HEMISPHERX ANNOUNCES FIRST QUARTER RESULTS REVENUE INCREASED-NET LOSS REDUCED BY 40%
May 01, 2002
PRESIDENT/OWNER OF MAJOR INTERNATIONAL OIL EXPLORATION COMPANIES JOINS HEMISPHERX BIOPHARMA BOARD OF DIRECTORS
Apr 29, 2002
Hemispherx Announces Formation of Committee to Initiate Search For Medical Director to Lead its HIV/AIDS Division
Apr 18, 2002
Hemispherx and The AIDS Community Research Initiative of America -- ACRIA -- Launch Immunotherapeutic HIV/AIDS Clinical Trials in New York City
69
70
71
72
73
74
75
76
<<
<
>
>>
Privacy